ATE180168T1 - Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus - Google Patents

Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus

Info

Publication number
ATE180168T1
ATE180168T1 AT93922725T AT93922725T ATE180168T1 AT E180168 T1 ATE180168 T1 AT E180168T1 AT 93922725 T AT93922725 T AT 93922725T AT 93922725 T AT93922725 T AT 93922725T AT E180168 T1 ATE180168 T1 AT E180168T1
Authority
AT
Austria
Prior art keywords
diabetes mellitus
dependent diabetes
prevent insulin
insulin
prevent
Prior art date
Application number
AT93922725T
Other languages
English (en)
Inventor
Martha W Bond
Kevin W Moore
Kenneth Pennline
Paul J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE180168T1 publication Critical patent/ATE180168T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT93922725T 1992-10-01 1993-09-28 Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus ATE180168T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01

Publications (1)

Publication Number Publication Date
ATE180168T1 true ATE180168T1 (de) 1999-06-15

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93922725T ATE180168T1 (de) 1992-10-01 1993-09-28 Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus

Country Status (23)

Country Link
EP (1) EP0662837B1 (de)
JP (1) JP2739770B2 (de)
KR (1) KR0166663B1 (de)
CN (1) CN1093598A (de)
AT (1) ATE180168T1 (de)
AU (1) AU689448B2 (de)
CA (1) CA2145863A1 (de)
CZ (1) CZ286866B6 (de)
DE (1) DE69325029T2 (de)
DK (1) DK0662837T3 (de)
ES (1) ES2131122T3 (de)
FI (1) FI951511A7 (de)
GR (1) GR3030269T3 (de)
HU (1) HU217871B (de)
IL (1) IL107153A (de)
MX (1) MX9306043A (de)
MY (1) MY111543A (de)
NO (1) NO951240L (de)
SG (1) SG48733A1 (de)
SK (1) SK281806B6 (de)
TW (1) TW336172B (de)
WO (1) WO1994008606A1 (de)
ZA (1) ZA937244B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507452A (pt) * 1994-04-08 1997-08-05 Brigham & Womens Hospital Composição farmacêutica uso de um polipeptídeo não-interferon uso de uma quantidade de um antígeno padronizado e uma quantidade de um polipeptídeo não-interferon e produto contendo (1) uma quantidade de um antígeno padronizado e (11) uma quantidade de um polipeptídeo não-interferon
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
EP1621206A1 (de) * 1994-12-12 2006-02-01 Beth Israel Deaconess Medical Center, Inc. Chimäre Zytokine und ihre Verwendung
WO1997005895A1 (en) * 1995-08-07 1997-02-20 Schering Corporation Treatment of ocular inflammatory conditions with interleukin-10
AU712606B2 (en) * 1995-08-09 1999-11-11 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
US5939069A (en) 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
AU8671798A (en) * 1997-07-30 1999-02-22 Betagene, Inc. Methods and compositions relating to no-mediated cytotoxicity
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
ES2237850T3 (es) * 1997-10-14 2005-08-01 Mitsubishi Pharma Corporation Compuestos de piperazina y su uso medicinal.
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
US9962428B2 (en) 2012-12-21 2018-05-08 National University Corporation Nagoya University Composition having tissue-repairing activity, and use therefor
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
ES2930351T3 (es) 2016-04-15 2022-12-09 Evive Biotechnology Shanghai Ltd Un dímero de IL-22 para su uso en el tratamiento de enterocolitis necrosante
WO2021164744A1 (en) 2020-02-19 2021-08-26 Evive Biotechnology (Shanghai) Ltd Methods for treating graft versus host disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
SK42395A3 (en) 1997-01-08
SG48733A1 (en) 1998-05-18
HU217871B (hu) 2000-04-28
DE69325029D1 (de) 1999-06-24
DK0662837T3 (da) 1999-11-08
JPH07507567A (ja) 1995-08-24
ZA937244B (en) 1994-06-27
WO1994008606A1 (en) 1994-04-28
TW336172B (en) 1998-07-11
IL107153A0 (en) 1993-12-28
HUT71421A (en) 1995-11-28
CZ286866B6 (en) 2000-07-12
KR0166663B1 (en) 1999-01-15
HU9500933D0 (en) 1995-05-29
FI951511A0 (fi) 1995-03-30
EP0662837B1 (de) 1999-05-19
IL107153A (en) 2000-07-16
CZ80495A3 (en) 1996-01-17
GR3030269T3 (en) 1999-08-31
EP0662837A1 (de) 1995-07-19
SK281806B6 (sk) 2001-08-06
FI951511L (fi) 1995-03-30
AU5163593A (en) 1994-05-09
KR950703353A (ko) 1995-09-20
HK1008812A1 (en) 1999-05-21
ES2131122T3 (es) 1999-07-16
FI951511A7 (fi) 1995-03-30
JP2739770B2 (ja) 1998-04-15
NO951240L (no) 1995-05-30
DE69325029T2 (de) 1999-10-07
MX9306043A (es) 1994-04-29
AU689448B2 (en) 1998-04-02
CA2145863A1 (en) 1994-04-28
CN1093598A (zh) 1994-10-19
MY111543A (en) 2000-08-30
NO951240D0 (no) 1995-03-30

Similar Documents

Publication Publication Date Title
DE69325029D1 (de) Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus
ATE139120T1 (de) Verwendung von rapamycin zur behandlung des diabetes
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
YU39595A (sh) Dobijanje kristala stabilnog cinka insulinskog analoga
TW218869B (de)
ATE161536T1 (de) Neue mercaptoacetylamid-derivate zur verwendung als enkephalinase- und ace-hemmer
DE69830751D1 (de) Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
DE3878627D1 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
DE69123178D1 (de) Verwendung von Uridin zur pharmakologischen Behandlung der peripheren Komplikationen bei Diabetes
DE3883606D1 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
ATE231131T1 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
KR950700738A (ko) 당뇨병 치료를 위한 퀴놀린-3-카르복시아미드 화합물의 용도(the use of quinoline-3-carboxamide compounds for treatment of diabetes)
BG44708A3 (bg) Метод за получаване на спиро-3-хетероазолони
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
DE69103294D1 (de) Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE69402241D1 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
TR21280A (tr) Bir kap icerisine yigilmis tarimsal *r*nlerin muamelesine mahsus usul
ATE74004T1 (de) Mischung zur behandlung von hypercholesterolemie.
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee